CEACAM5 and gastric cancer: Currently, only a few biomarkers are clinically used for early detection of GC, such as carbohydrate antigens (CA19-9, CA72-4, CA125, CA24-2, CA50), carcinoembryonic antigen (CEA), pepsinogen, and α-fetoprotein (AFP).